PROJECT

Projects

Summary of Investment Information

Project Number

44558

Company Name

NOBEL ILAC SANAYII VE TICARET A.S.

Date SPI Disclosed

Feb 18, 2021

Country

Turkiye

Region

Central Asia and Turkiye

Projected Board Date

Mar 23, 2021

Environmental Category

B - Limited

Status

Active

Last Updated Date

Jul 10, 2021

Department

Regional Industry MAS MCT

Industry

other

Previous Events

Approved : Mar 31, 2021
Signed : Apr 30, 2021
Invested : Jul 1, 2021

Sector

other

Project Description

The proposed IFC investment consists of a senior loan to Nobel Ilac Sanayii ve Ticaret A.S. (“Nobel” or the “Company”) in form of an A Loan up to EUR10 million or its USD or TRY equivalent. The IFC loan fits into IFC’s crisis response for Covid-19 financing and will reduce Nobel’s working capital pressure triggered by the effects of Covid-19. That way, Nobel will uninterruptedly carry out its ongoing capex program in the areas of injectables and bio-technology.

Nobel is a Turkish generic pharmaceuticals company that produces, markets, distributes and sells products domestically and exports across Europe and Central Asia. Its product portfolio is spread across chronic, acute and consumer health therapeutic areas.

Associated Advisory Engagement

N/A

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation